Increased Severity of COVID-19 in People with Obesity: Are We Overlooking Plausible Biological Mechanisms?
作者信息
Tibiriçá Eduardo, De Lorenzo Andrea
机构信息
Research and Teaching Department, Instituto Nacional de Cardiologia, Rio de Janeiro, Brazil.
出版信息
Obesity (Silver Spring). 2020 Aug;28(8):1374. doi: 10.1002/oby.22887. Epub 2020 Jul 6.
Abstract
摘要
相似文献
1
Increased Severity of COVID-19 in People with Obesity: Are We Overlooking Plausible Biological Mechanisms?肥胖人群中新冠病毒疾病（COVID-19）病情加重：我们是否忽略了合理的生物学机制？
Obesity (Silver Spring). 2020 Aug;28(8):1374. doi: 10.1002/oby.22887. Epub 2020 Jul 6.
2
Does Coronavirus Disease 2019 Disprove the Obesity Paradox in Acute Respiratory Distress Syndrome?2019冠状病毒病是否反驳了急性呼吸窘迫综合征中的肥胖悖论？
Obesity (Silver Spring). 2020 Jun;28(6):1007. doi: 10.1002/oby.22835.
3
Corticosteroid use in selected patients with severe acute respiratory distress syndrome related to COVID-19.在部分与新型冠状病毒肺炎相关的严重急性呼吸窘迫综合征患者中使用皮质类固醇。
J Infect. 2020 Aug;81(2):e89-e90. doi: 10.1016/j.jinf.2020.05.023. Epub 2020 May 14.
4
Extracorporeal membrane oxygenation for acute respiratory distress syndrome in patients with coronavirus disease 2019: what do we know so far?2019冠状病毒病患者急性呼吸窘迫综合征的体外膜肺氧合：我们目前了解多少？
Perfusion. 2020 Sep;35(6):558-561. doi: 10.1177/0267659120934279. Epub 2020 Jun 24.
5
Heterogeneity of Acute Respiratory Distress Syndrome in COVID-19: "Typical" or Not?新型冠状病毒肺炎中急性呼吸窘迫综合征的异质性：是否为“典型”？
Am J Respir Crit Care Med. 2020 Aug 15;202(4):618-619. doi: 10.1164/rccm.202004-1106LE.
6
Bronchiolitis and Potential Pathophysiological Implications in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome Patients With Near-Normal Respiratory Compliance.2019冠状病毒病急性呼吸窘迫综合征患者呼吸顺应性接近正常时的细支气管炎及潜在病理生理意义
Crit Care Med. 2020 Oct;48(10):e993-e994. doi: 10.1097/CCM.0000000000004470.
7
Proning During COVID-19: The Importance of Teamwork.新冠疫情期间的俯卧位通气：团队协作的重要性。
Am J Crit Care. 2020 Nov 1;29(6):418. doi: 10.4037/ajcc2020542.
8
Dealing With the CARDS of COVID-19.应对新冠疫情这副“牌”。
Crit Care Med. 2020 Aug;48(8):1239-1241. doi: 10.1097/CCM.0000000000004427.
9
Ethics and extracorporeal membrane oxygenation during coronavirus disease 2019 outbreak.2019冠状病毒病疫情期间的伦理与体外膜肺氧合
Perfusion. 2020 Sep;35(6):562-564. doi: 10.1177/0267659120937545. Epub 2020 Jun 25.
10
Covid-19, Angiogenesis, and ARDS Endotypes.新型冠状病毒肺炎、血管生成与急性呼吸窘迫综合征的内型
N Engl J Med. 2020 Jul 9;383(2):182-183. doi: 10.1056/NEJMe2018629. Epub 2020 May 21.
引用本文的文献
1
Interplay between Comorbidities and Long COVID: Challenges and Multidisciplinary Approaches.共病与长新冠之间的相互作用：挑战和多学科方法。
Biomolecules. 2024 Jul 11;14(7):835. doi: 10.3390/biom14070835.
2
Reviving the mutual impact of SARS-COV-2 and obesity on patients: From morbidity to mortality.重新审视 SARS-COV-2 和肥胖症对患者的相互影响：从发病率到死亡率。
Biomed Pharmacother. 2022 Jul;151:113178. doi: 10.1016/j.biopha.2022.113178. Epub 2022 May 24.
3
A Review of SARS-CoV2: Compared With SARS-CoV and MERS-CoV.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）综述：与严重急性呼吸综合征冠状病毒（SARS-CoV）和中东呼吸综合征冠状病毒（MERS-CoV）的比较
Front Med (Lausanne). 2021 Dec 7;8:628370. doi: 10.3389/fmed.2021.628370. eCollection 2021.
4
[Obesity - A Risk Factor for Psoriasis and COVID-19].[肥胖——银屑病和新冠病毒病的一个风险因素]
Actas Dermosifiliogr. 2021 Jun;112(6):489-494. doi: 10.1016/j.ad.2020.12.001. Epub 2020 Dec 24.
5
Determinants of endothelial dysfunction in noncritically ill hospitalized COVID-19 patients: A cross-sectional study.非危重症住院 COVID-19 患者内皮功能障碍的决定因素：一项横断面研究。
Obesity (Silver Spring). 2022 Jan;30(1):165-171. doi: 10.1002/oby.23311. Epub 2021 Nov 23.
6
The impact of COVID-19 on obesity services across Europe: A physician survey.新冠疫情对欧洲肥胖症服务的影响：一项医生调查。
Clin Obes. 2021 Oct;11(5):e12474. doi: 10.1111/cob.12474. Epub 2021 Jul 13.
7
Obesity and Disease Severity Among Patients With COVID-19.2019冠状病毒病患者的肥胖与疾病严重程度
Cureus. 2021 Feb 5;13(2):e13165. doi: 10.7759/cureus.13165.
8
Systemic microvascular endothelial dysfunction and disease severity in COVID-19 patients: Evaluation by laser Doppler perfusion monitoring and cytokine/chemokine analysis.新型冠状病毒肺炎患者的系统性微血管内皮功能障碍和疾病严重程度：激光多普勒灌注监测和细胞因子/趋化因子分析评估。
Microvasc Res. 2021 Mar;134:104119. doi: 10.1016/j.mvr.2020.104119. Epub 2020 Dec 3.
9
Systemic microvascular dysfunction in COVID-19.新冠病毒病中的全身微血管功能障碍
Am J Cardiovasc Dis. 2020 Oct 15;10(4):386-391. eCollection 2020.
10
Tackling obesity during the COVID-19 pandemic.在新冠疫情期间应对肥胖问题。
Diabetes Metab Res Rev. 2021 Mar;37(3):e3393. doi: 10.1002/dmrr.3393. Epub 2020 Aug 29.
本文引用的文献
1
The Role of Adipocytes and Adipocyte-Like Cells in the Severity of COVID-19 Infections.脂肪细胞和脂肪细胞样细胞在 COVID-19 感染严重程度中的作用。
Obesity (Silver Spring). 2020 Jul;28(7):1187-1190. doi: 10.1002/oby.22856. Epub 2020 Jun 10.
2
Targeting the Adipose Tissue in COVID-19.针对新冠病毒肺炎中的脂肪组织
Obesity (Silver Spring). 2020 Jul;28(7):1178-1179. doi: 10.1002/oby.22844. Epub 2020 May 21.
3
Cytokine release syndrome in severe COVID-19.重症新型冠状病毒肺炎中的细胞因子释放综合征
Science. 2020 May 1;368(6490):473-474. doi: 10.1126/science.abb8925. Epub 2020 Apr 17.
4
Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis.微血管性新冠肺炎肺血管阻塞性血栓炎症综合征（MicroCLOTS）：一种非典型急性呼吸窘迫综合征的工作假说。
Crit Care Resusc. 2020 Apr 15;22(2):95-97. doi: 10.51893/2020.2.pov2.
5
Does Coronavirus Disease 2019 Disprove the Obesity Paradox in Acute Respiratory Distress Syndrome?2019冠状病毒病是否反驳了急性呼吸窘迫综合征中的肥胖悖论？
Obesity (Silver Spring). 2020 Jun;28(6):1007. doi: 10.1002/oby.22835.
Zotero 插件